Manufacturing and Distribution Boundaries Blur

Airlines, airports, freight forwarders, and other cold-chain partners are taking a crash course in pharma cGMPs.
Pharmaceutical distribution was once considered separately, as a simple handoff. Manufacturers made product, then had it shipped (by a reputable company and its partners) to its destination. This approach ignored the modes and nodes, numerous product transfers, and players involved in the logistics process. It also predated biotech, and a clear understanding of just how sensitive biopharmaceuticals can be to the slightest changes in temperature, pressure, humidity, or other conditions. Today, logistics providers and pharmaceutical manufacturers agree, simple handoffs no longer work.
Source: Pharmtech